Clinical characteristics and treatment progress of adolescent and young adult with colorectal cancer

doi:10.3760/cma.j.issn.1673-422X.2017.04.018

Abstract

Yan Hongkai, Liu Chaoxu, Song Ning, Shi Liubin. Clinical characteristics and treatment progress of adolescent and young adult with colorectal cancer[J]. Journal of International Oncology, 2017, 44(4): 307-309.

References

［1］ Kansakar P, Singh Y. Changing trends of colorectal carcinoma in nepalese young adults［J］. Asian Pac J Cancer Prev, 2012, 13(7): 3209-3212. ［2］ Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975—2010［J］. JAMA Surg, 2015, 150(1): 17-22. DOI: 10.1001/jamasurg.2014.1756. ［3］ Smith AW, Seibel NL, Lewis DR, et al. Next steps for adolescent and young adult oncology workshop: an update on progress and recommendations for the future［J］. Cancer, 2016, 122(7): 988-999. DOI: 10.1002/cncr.29870. ［4］ Tricoli JV, Blair DG, Anders CK, et al. Biologic and clinical characteristics of adolescent and young adult cancers: acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma［J］. Cancer, 2016, 122(7): 1017-1028. DOI: 10.1002/cncr.29871. ［5］ Zhu C, Ji M, Dai W, et al. Clinicopathological characteristics of Chinese colorectal cancer patients under 30 years old: implication in diagnosis and therapy［J］. Curr Cancer Drug Targets, 2015, 15(1): 2734. ［6］ Wang MJ, Ping J, Li Y, et al. The prognostic factors and multiple biomarkers in young patients with colorectal cancer［J］. Sci Rep, 2015， 5: 10645. DOI: 10.1038/srep10645. ［7］ Ballester V, Rashtak S, Boardman L. Clinical and molecular features of young-onset colorectal cancer［J］. World J Gastroenterol, 2016, 22(5): 1736-1744. DOI: 10.3748/wjg.v22.i5.1736. ［8］ Stigliano V, Sanchez-Mete L, Martayan A, et al. Early-onset colorectal cancer: a sporadic or inherited disease?［J］. World J Gastroenterol, 2014, 20(35): 12420-12430. DOI: 10.3748/wjg.v20.i35.12420. ［9］ Provenzale D, Gupta S, Ahnen DJ, et al. Genetic/familial high-risk assessment: colorectal version 1.2016, NCCN clinical practice guidelines in oncology［J］. J Natl Compr Canc Netw, 2016, 14(8): 1010-1030. ［10］ You YN, Xing Y, Feig BW, et al. Young-onset colorectal cancer: is it time to pay attention?［J］. Arch Intern Med, 2012, 172(3): 287-289. DOI: 10.1001/archinternmed.2011.602. ［11］ Davis DM, Marcet JE, Frattini JC, et al. Is it time to lower the recommended screening age for colorectal cancer?［J］. J Am Coll Surg, 2011, 213(3): 352-361. DOI: 10.1016/j.jamcollsurg.2011.04.033. ［12］ Liang JT, Huang KC, Cheng AL, et al. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age［J］. Br J Surg, 2003, 90(2): 205-214. ［13］ Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: a call to action［J］. Mayo Clin Proc, 2014, 89(2): 216-224. DOI: 10.1016/j.mayocp.2013.09.006. ［14］ Perea J, Rueda D, Canal A, et al. Age at onset should be a major criterion for subclassification of colorectal cancer［J］. J Mol Diagn, 2014, 16(1): 116-126. DOI: 10.1016/j.jmoldx.2013.07.010. ［15］ Young JP, Win AK, Rosty C, et al. Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review［J］. J Gastroenterol Hepatol, 2015, 30(1): 6-13. DOI: 10.1111/jgh.12792. ［16］ Franceschi S, Favero A, La VC, et al. Food groups and risk of colorectal cancer in Italy［J］. Int J Cancer, 1997, 72(1): 56-61. ［17］ Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States［J］. Cancer Epidemiol Biomarkers Prev, 2009, 18(6): 1695-1698. DOI: 10.1158/1055-9965. ［18］顾飞英, 袁瑛. 肿瘤分子标志物与个体化治疗［J］. 国际肿瘤学杂志, 2012, 39(6): 428-431. DOI: 10.3760/cma.j.issn.1673-422X.2012.06. 009. ［19］ Benson AB 3rd, Bekaii-Saab T, Chan E, et al. Localized colon cancer, version 3.2013: featured updates to the NCCN guidelines［J］. J Natl Compr Canc Netw, 2013, 11(5): 519-528. ［20］ Inra JA, Syngal S. Colorectal cancer in young adults［J］. Dig Dis Sci, 2015, 60(3): 722-733. DOI: 10.1007/s10620-014-3464-0. ［21］ O′Connell JB, Maggard MA, Livingston EH, et al. Colorectal cancer in the young［J］. AM J Surg, 2004, 187(3): 343-348. ［22］ Teng A, Lee DY, Cai J, et al. Patterns and outcomes of colorectal cancer in adolescents and young adults［J］. J Surg Res, 2016, 205(1): 19-27. DOI: 10.1016/j.jss.2016.05.036. ［23］ Haggar FA, Preen DB, Pereira G, et al. Cancer incidence and mortality trends in Australian adolescents and young adults, 1982—2007［J］. BMC Cancer, 2012, 12(1): 151. DOI: 10.1186/1471-2407-12-151. ［24］ Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer［J］. Ann Surg Oncol, 2007, 14(10): 2759-2765. DOI: 10.1245/s10434-007-9465-x. ［25］ Gondos A, Hiripi E, Holleczek B, et al. Survival among adolescents and young adults with cancer in Germany and the United States: an international comparison［J］. Int J Cancer, 2013, 133(9): 2207-2215. DOI: 10.1002/ijc.28231. ［26］ Kumar S, Burney IA, Zahid KF, et al. Colorectal cancer patient characteristics, treatment and survival in Omana—a single center study［J］. Asian Pac J Cancer Prev, 2015, 16(12): 4853-4858. ［27］ Wang R, Wang MJ, Ping J. Clinicopathological features and survival outcomes of colorectal cancer in young versus elderly: a population-based cohort study of SEER 9 registries data (1988-2011)［J］. Medicine (Baltimore), 2015, 94(35): e1402. DOI: 10.1097/MD.0000000000001402. ［28］ Vatandoust S, Price T J, Ullah S, et al. Metastatic colorectal cancer in young adults: a study from the south Australian population-based registry［J］. Clin Colorectal Cancer, 2016, 15(1): 32-36. DOI: 10.1016/j.clcc.2015.07.005. ［29］ Park SK, Kim NH, Jung YS, et al. Risk of developing advanced colorectal neoplasia after removing high-risk adenoma detected at index colonoscopy in young patients: a KASID study［J］. J Gastroenterol Hepatol, 2016, 31(1): 138-144. DOI: 10.1111/jgh.13167.

[1]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[2]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[3]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[4]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118.
[5]	Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong. Expression and clinical significance of ASB6 in colorectal cancer tissues [J]. Journal of International Oncology, 2023, 50(8): 470-474.
[6]	Chen Zhuo, Tao Jun, Chen Lin, Ke Jing. Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer [J]. Journal of International Oncology, 2023, 50(5): 268-273.
[7]	Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun. Construction of postoperative prognosis model for patients with colorectal cancer [J]. Journal of International Oncology, 2023, 50(3): 157-163.
[8]	Xu Liangfu, Li Yuanfei. Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer [J]. Journal of International Oncology, 2023, 50(3): 186-190.
[9]	Liu Yujie, Zhao Zhiqiang, Wang Zicheng. Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer [J]. Journal of International Oncology, 2023, 50(12): 717-722.
[10]	Tao Hong, Yin Hong, Luo Hong, Tao Jiayu. Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer [J]. Journal of International Oncology, 2023, 50(11): 683-687.
[11]	Wang Xi, Wu Chuanqing. Research progress in reversing multidrug resistance in colorectal cancer [J]. Journal of International Oncology, 2023, 50(1): 42-46.
[12]	Gao Yizhao, Liu Yang, Liu Qiulong, Xing Jinliang. Application of circulating cell-free nucleic acid in clinical diagnosis and treatment of colorectal cancer [J]. Journal of International Oncology, 2022, 49(9): 555-559.
[13]	He Zhefeng, Wu Yiyang, Li Zhenjun, Ying Xiaojiang. Predictive value of inflammatory markers in colorectal cancer [J]. Journal of International Oncology, 2022, 49(9): 560-563.
[14]	Zhao Ying, Zhang Gehong. Study on the correlations between AGR, PLR and NLR changes and chemotherapy efficacy of metastatic colorectal cancer [J]. Journal of International Oncology, 2022, 49(8): 473-477.
[15]	Huang Mengpan, Wang Xuehong, Lu Yongfu. Mechanism of FOXA2 in colorectal cancer and its application in diagnosis and treatment [J]. Journal of International Oncology, 2022, 49(8): 490-493.